David Bluemke

Dr. David Bluemke

Director,Department of Radiology and Imaging Sciences at the NIH Clinical Center

Dr. Bluemke earned his medical degree at the University of Chicago's Pritzker School of Medicine as part of the Medical Scientist Training Program and his PhD from the University of Chicago's Department of Biophysics and Theoretical Biology, where he studied the evaluation of three-dimensional macromolecules using advanced computer modeling techniques. He also holds an undergraduate degree in chemical engineering from the University of Wisconsin-Madison and a Master of Science in business from Johns Hopkins University. His training includes a fellowship in cross-sectional imaging in diagnostic radiology at Johns Hopkins School of Medicine and residency at the Johns Hopkins Hospital. He is a fellow of the American Heart Association, American College of Radiology and the North American Society of Cardiovascular Imaging.  Currently Dr. Bluemke is Director, Department of Radiology and Imaging Sciences at the NIH Clinical Center

Dr. Bluemke's research focuses on cardiovascular disease and its complications and seeks to better understand especially how subclinical disease can be detected with newly developed imaging technologies, described, and tracked over time. His group was the first to describe the use of myocardial delayed enhancement in arrhythmogenic right ventricular dysplasia (ARVD), and the first to document quantitative evaluation of cardiac function in this condition, as well as normal variations of the geometry of the right heart. He was the principal investigator of the MRI reading center for the U.S. ARVD multi-center trial. Under Dr. Bluemke's direction, the Johns Hopkins Division of MRI was also one of the first groups to demonstrate a method for multi-station MRI angiography and for the intravascular assessment of ultra-high resolution evaluation of atherosclerotic plaque in humans. His area of expertise in imaging also extends to oncologic disease and the evaluation of cancer with MRI. Dr. Bluemke was a lead author on four large, multi-center clinical trials evaluating the use of novel contrast for MRI for oncologic applications, the largest multi-study of MRI in the evaluation of breast cancer, and a multi-center trial in cardiovascular disease. He is currently studying cardiovascular disease with MRI in the Epidemiology of Diabetes Interventions and Complications (EDIC) trial of more than 1000 type 1 diabetic patients and the Multi-Ethnic Study of Atherosclerosis (MESA) study of 6800 individuals. Ongoing NIH protocols include the study of patients with heart failure and hypertrophic cardiomyopathy using advanced imaging techniques.

Dr. Bluemke has shared this knowledge by teaching more than 50 post-graduate trainees from across North America and internationally in radiology and cardiology. He has also lectured at more than 200 international and national conferences, CME events, and society meetings.

He is a member of the board of trustees for the Internal Society of Magnetic Resonance in Medicine (ISMRM), board member of the North American Society of Cardiovascular Imaging and Society of Cardiovascular Magnetic Resonance, past chair of the American College of Radiology (ACR) Cardiac Accreditation Committee, and past program chair of the ISMRM Cardiac MR Study Group. He has been appointed to the American Heart Association Council on Radiology and Intervention, the ACR Committee on Standards for Body MRI, and the ACR Committee on Standards and Accreditation for Magnetic Resonance.

编辑: xy 作者:丁香园通讯员

以下网友留言只代表网友个人观点，不代表网站观点

昵称：游客 请登录或注册后，发表留言

验证码：